Medicine

All Articles

Prenatal direct exposure to scarcity impacts lifelong wellness

.Attributes Medication, Published online: 09 September 2024 doi:10.1038/ d41591-024-00068-4Analysis ...

A global metric of invulnerable health

.Attribute Medication, Published online: 05 September 2024 doi:10.1038/ s41591-024-03210-4A research...

Niacin, food items intake as well as heart results

.Attributes Medicine, Published online: 05 September 2024 doi:10.1038/ s41591-024-03220-2Niacin, foo...

Opportunities and difficulties for patient-reported end result assessment in multimorbidity study as well as method

.Contending rate of interests.S.E.H. receives funding coming from the National Principle of Health A...

Hibernation science harnessed to handle being overweight and tweak metabolic process

.Nature Medication, Released online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy knowing the...

CAR- T and cell gene therapies are actually also expensive

.Nature Medication, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care ...

The WHO genomics course of work with fair implementation of individual genomics for global wellness

.The magazine of the first draft of the individual genome series in 20011 was actually followed due ...

A time-stratified, case\u00e2 $ \"crossover research of heat energy direct exposure and perinatal death coming from 16 healthcare facilities in sub-Saharan Africa

.One of 138,015 hospital-based individual births in 4 sub-Saharan African nations, our experts notic...

Advancing worldwide antibiotic research, growth and get access to #.\n\nMurray, C. J. L. et cetera. International worry of bacterial antimicrobial protection in 2019: a step-by-step review. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Leaders. In the direction of specific commitments and action in the reaction to antimicrobial resistance. International Frontrunners Team on Antimicrobial Protection https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). World Wellness Association. WHO publishes listing of micro-organisms for which brand-new prescription antibiotics are urgently required. Planet Wellness Organization https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). Globe Health And Wellness Organization. WHO microbial priority microorganisms list, 2024: microbial pathogens of public health relevance to assist research, growth and also techniques to prevent and also regulate antimicrobial protection. Planet Health and wellness Organization https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt way to Gram-negative access. Bioorg. Med. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic resistance. Ups. J. Med. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle Scholar\u00c2.\nWorld Health Institution. 2023 anti-bacterial representatives in medical and preclinical growth: a summary as well as evaluation. Globe Health and wellness Institution https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et al. AMR Review. May 19, 2016 \u00e2 $\" Dealing with drug-resistant contaminations around the world: ultimate report and also referrals. Customer Review on Antimicrobial Resistance https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Range. DRIVE-AB outcomes: records and instruction. Drive abdominal https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et al. Appearing the wall structure: a call for collective action on anti-biotics research and development. Boston ma Consulting Group https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Policy Concise 51: How can the EU help lasting innovation and access to reliable antibiotics? policy possibilities for existing and new medications. International Observatory on Health Equipments as well as Policies https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Antibiotic use and resistance\u00e2 $\" verifying the obvious. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPlanet Wellness Company. 2021 Knowledgeable category. WHO get access to, check out, reserve, distinction of prescription antibiotics for evaluation and also monitoring of use. Globe Wellness Association https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). European Facility for Disease Prevention and Command. Antimicrobial protection intendeds: exactly how can we reach all of them through 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). Globe Health Company. Absence of innovation readied to weaken antibiotic efficiency as well as health and wellness increases. World Wellness Institution https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et cetera. Exactly how antimicrobial resistance is linked to temperature change: an overview of two entwined global challenges. Int. J. Environ. Res. Public Health twenty, 1681 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant bacterial diseases: our experts require immediate action and assets that focus on the weakest hyperlink. PLoS Biol. Twenty, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nWorld Wellness Company. Booster shot protection. World Health Association https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Disease avoidance and command in low-resource environments: the requirement for the local, the contextual and also the pragmatic. Infect. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Challenges of carrying out antimicrobial stewardship resources in reduced to middle revenue countries (LMICs). Contaminate. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nAminov, R. A quick past of the antibiotic time: sessions found out as well as problems for the future. Face. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K. et al. Individual access in 14 high-income nations to brand-new antibacterials accepted by the United States Food and Drug Administration, European Medicines Organization, Japanese Pharmaceuticals and also Medical Devices Organization, or even Wellness Canada, 2010\u00e2 $ \"2020. Clin. Contaminate. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nGlobe Wellness Association. 2021 anti-bacterial brokers in professional as well as preclinical development: a guide and review. Globe Wellness Company https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Antibiotics: the economics should sustain the scientific research. Attribute 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The condition of advancement in anti-bacterial therapies. Biotechnology Innovation Organization https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et al. Analyzing medical professional use of next-generation anti-biotics against resisting Gram-negative diseases in united state healthcare facilities: a retrospective pal study. Ann. Trainee. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nThomas, D. &amp Wessel, C. The state of innovation in antibacterial therapies. Medical Innovation Company https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. An organized evaluation and essential evaluation of reward approaches for revelation as well as development of unique prescription antibiotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nHealth Emergency Preparedness as well as Feedback Authorization. R &amp d of medical countermeasures. European Commission https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). International Percentage. Pre-draft proposal for an European alliance under Horizon Europe One Health Antimicrobial Protection. International Payment https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). International Anti-biotic Trial And Error Partnership. Entasis Therapies as well as the Global Anti-biotic Study &amp Progression Collaboration to cultivate a new therapy for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of business- and also non-industry-sponsored scientific tests. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPlanet Health And Wellness Institution. Number of professional trial signs up by site, condition, phase of progression, age and sex of test participants (1999\u00e2 $ \"2022). Planet Wellness Company https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). Global Antibiotic R &amp D Relationship. NeoSept1: a study to establish the rank of existing as well as brand-new prescription antibiotics blends to manage newborn babies that reside in medical center along with serious blood poisoning. ISRCTN windows registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Hygienics Agency of Canada. Government of Canada brings in necessary expenditure to fight antimicrobial resistance (AMR), Federal government of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). Worldwide Antibiotic Trial And Error Relationship. Asia federal government financing assists GARDP\u00e2 $ s attempts to resist antibiotic resistance. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 October 2023). Novo Nordisk Foundation. Novo Nordisk Structure partners along with CARB-X to eliminate drug-resistant infections. novo nordisk groundwork https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). European Commission: European Health as well as Digital Exec Firm. Research on carrying AMR clinical countermeasures to the market place. Publications Office of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Approximating the appropriate size of global pull motivations for anti-bacterial medications. Health and wellness Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Dimensions a market entry reward for the growth of brand-new prescription antibiotics. Harvard Kennedy College https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et al. Sector rewards as well as antibiotic protection: an overview to the antibiotic vulnerability incentive. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nBonnifield, R. &amp Towse, A. A determined USG accelerated dedication for subscription-based obtaining of unique antimicrobials and its own expected return on investment. Center for Global Advancement https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 Nov 2022). Towse, A. &amp Silverman Bonnifield, R. G7 financial investments in brand new prescription antibiotics would pay \u00e2 $\" for everybody. Office of Health and wellness Business economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS boosts war versus serious infections adhering to prosperous world-first pilot. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). United States Congress. S. 1355 \u00e2 $\" PASTEUR Action of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). European Commission. Reform of the EU pharmaceutical legalisation. International Payment https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et cetera. Reimbursement styles to tackle market failures for antimicrobials: techniques enjoyed France, Germany, Sweden, the United Kingdom, and also the USA. Wellness Policy 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nInternational Alliance of Drug Manufacturers and Affiliations. From protection to resilience: what could the potential antibiotic pipeline seem like? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). Global AMR R&ampD Hub &amp Globe Wellness Organization. Incentivising the growth of brand-new antibacterial procedures: 2023 report card due to the International AMR R&ampD Hub as well as WHO. Global AMR R&ampD Center https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Singer, A., Roberts, A. P. &amp Kirchhelle, C. Why is the UK membership version for antibiotics looked at prosperous? Lancet Micro organism 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNon-paper \u00e2 $\" unfamiliar stimuli for the progression and keeping on the marketplace of antimicrobials. Politico https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et al. Global, regional, as well as national root causes of kid mortality in 2000\u00e2 $ \"thirteen, with forecasts to inform post-2015 top priorities: an improved methodical evaluation. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nQuadri, F. et cetera. Anti-bacterial medicine lacks coming from 2001 to 2013: effects for professional practice. Clin. Contaminate. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nBenhabib, A. et al. The French coverage device for drug scarcities: summary and also patterns coming from 2012 to 2018: an empirical retrospective study. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nKlein, E. Y. et cetera. Evaluation of that antibiotic usage and gain access to aim ats in 76 nations, 2000\u00e2 $ \"15: a study of pharmaceutical sales data. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Dealing with the fakes: tackling shoddy as well as falsified medicines. Nat. Rev. Dis. Primers 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it getting less complicated to secure antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nBlack Society for Lab Medication. Plan concise as well as infographics on antimicrobial resistance (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et cetera. National antibiotic consumption for individual use in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional research study. Trop. Medication. Contaminate. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nNamugambe, J. S. et al. National antimicrobial consumption: evaluation of main warehouses items to in-patient care health locations coming from 2017 to 2019 in Uganda. Trop. Medication. Contaminate. Dis. 6, 83 (2021 ).\nGoogle Scholar\u00c2.\nRobertson, J. et cetera. Variations in the intake of antimicrobial medicines in the International area, 2014\u00e2 $ \"2018: results as well as effects from ESAC-Net as well as That Europe. Face. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nShukar, S. et al. Medication deficiency: causes, impact, as well as minimization approaches. Face. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Client access in 14 high-income countries to brand new antibacterials authorized by the United States Fda, European Medicines Organization, Japanese Pharmaceuticals and Medical Instruments Organization, or even Wellness Canada, 2010\u00e2 $ \"2020. Clin. Contaminate. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nPulcini, C. et al. Lost antibiotics: a follow-up supply research study in Europe, the United States, Canada and Australia. Int. J. Antimicrob. Agents 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted health technology for global health. Br. Medication. J. 366, 15601 (2019 ).\nGoogle Scholar\u00c2.\nAMR Field Alliance. The 2023 AMR Industry Partnership development poll: production and also the environment. amr Field Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Venture, D. &amp Gaule, P. Can medical items be cultivated on a charitable manner? Looking into item progression partnerships for ignored conditions. Sci. Public Policy 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nSwaminathan, S. et al. Reboot biomedical R&ampD in the international public rate of interest. Attributes 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nAfrica Centres for Ailment Command and Prevention. Africa CDC directs vibrant move to protect Africa\u00e2 $ s health and wellness future through developing a fifty billion buck clinical market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Gore, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Arranging public-health copyright licensing deals to enhance accessibility to health and wellness modern technologies: an insider\u00e2 $ s tale. BMJ Glob. Health 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New company designs for r &amp d along with price demands are actually needed to accomplish decent rates of medicines. Br. Medication. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nCombating Antibiotic-Resistant Microorganisms Biopharmaceutical Gas. Stewardship and get access to. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). International Antibiotic Trial And Error Relationship. Shinogi, GARDP and also CHAI announce landmark certificate and collaboration arrangements to handle microbial contaminations next to expanding access to cefiderocol in 135 nations. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Business Collaboration. Leaving behind the lab: tracking the decrease in AMR R&ampD professionals. amr Industry Alliance https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Wellness Ministers. G7 Wellness Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (20 May 2022). G20. G20 call to action on antimicrobial resistance. G7G20 Documents Data source https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 October 2022). Worldwide Coalition on Aging &amp Contagious Illness Society of America. 2024 AMR readiness mark progress report. Assessing authorities action on AMR plan. Global Union on Getting older https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food and also Farming Institution of the United Nations, United Nations Atmosphere Programme, Globe Health And Wellness Institution &amp. Planet Organisation for Creature Health And Wellness. International data source for tracking antimicrobial protection (AMR): nation self-assessment poll (TrACSS). That https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Vehicle Katwyk, S. R. &amp Outterson K. Introduction: AMR belongs in ...

Integrating liver endpoints in scientific trials of heart as well as renal illness

.Attribute Medicine, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point o...